Michael Wadanoli

Pfizer (United States) — United States

Medicine · Health Sciences

3h-index154citations5works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(4), Neonatal Respiratory Health Research(2), IL-33, ST2, and ILC Pathways(2), Respiratory Support and Mechanisms(1), Food Allergy and Anaphylaxis Research(1)

Publications5 total

Development of a model of Ascaris Suum antigen-induced pulmonary inflammation in nonhuman primates
Journal of Inflammation·2013· 1 citedOpen Access
Lipopolysaccharide (LPS) segmental lung challenge in nonhuman primates – a model of airway inflammation
Journal of Inflammation·2013Open Access
Interleukin-13 Neutralization by Two Distinct Receptor Blocking Mechanisms Reduces Immunoglobulin E Responses and Lung Inflammation in Cynomolgus Monkeys
Journal of Pharmacology and Experimental Therapeutics·2008· 45 cited
IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys
Journal of Allergy and Clinical Immunology·2007· 71 cited
The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time
Thrombosis and Haemostasis·2007· 37 cited

Frequent Co-authors

Andrea G. Bree(4), Franklin Schlerman(4), Samuel J. Goldman(4), Joseph P. Sypek(4), Lioudmila Tchistiakova(2), Kimberly Marquette(2), Xiangyang Tan(2), Angela Widom(2), T. Cook(2), Nancy Wood(2), Marion T. Kasaian(2), Bruce A. Jacobson(1), Suresh Vunnum(1), Rustem Krykbaev(1), Xin Xu(1), Debra D. Donaldson(1), Macy Jin(1), Lori Fitz(1), Julie Lee(1), Rita Agostinelli(1)